InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
7
T+90 hit rate
100%
T+90 mean return
+8.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Coffin Robert, Président et Responsable R&D. Insider active across 1 company, notably Replimune Group, Inc.. Aggregated, 9 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €1.8m. History available since 28 June 2021. The latest transaction was filed on 16 May 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
11,464 shares@ US$6.473.8% of flowCommon StockSEC:0001104659-24-063560:0
7,861 shares@ US$18.057.3% of flowCommon StockSEC:0001104659-23-062377:0
45,000 shares0Common StockSEC:0001104659-23-041718:0
5,737 shares@ US$14.590.019% mcap5.0% of flowCommon StockSEC:0001104659-22-062606:0
26,250 shares0Common StockSEC:0001104659-22-042771:0
7,810 shares@ US$40.040.061% mcap16.6% of flowCommon StockSEC:0001104659-21-089919:0
7,810 shares@ US$40.0414.7% of flowCommon StockSEC:0001104659-21-089919
14,663 shares@ US$40.0427.5% of flowCommon StockSEC:0001104659-21-087803
14,663 shares@ US$40.040.11% mcap30.9% of flowCommon StockSEC:0001104659-21-087803:0
9 of 9 declarations
About Coffin Robert
Robert Coffin is President & Chief R&D Officer at Replimune Group, Inc. He is responsible for leading the company's research and development efforts. His role is essential in guiding innovation initiatives and product development.
